25th Expert Committee on Selection and Use of Essential Medicines
The meeting of the 25th WHO Expert Committee on the Selection
and Use of Essential Medicines will be held at WHO Headquarters, Geneva,
from 5 to 9 May 2025 to
revise and update the WHO Model List of Essential Medicines (EML) and the WHO
Model List of Essential Medicines for Children (EMLc).
Applications for consideration by the Expert Committee
are published below.
Expert reviews, comments and other information related to the
meeting of the Expert Committee will also be published here as they become
available.
All enquiries regarding the Expert Committee meeting or the
application process should be directed to the EML Secretariat.
The Open Session of the meeting will be held on Monday 5 May 2025. Copies of presentations and statements made will be published here following completion of the Open Session.
The Secretary
Expert Committee on the Selection and Use of Essential Medicines
Medicines Selection, IP and Affordability (MIA)
Department of Health Products Policy and Standards (HPS)
20 Avenue Appia
CH-1211 Geneva 27
Email: emlsecretariat@who.int
Expert Committee Members
Infectious diseases specialist, University of Nairobi, Kenya
Professor of Medicine
Head, Center for Health Regulatory Policies at the Mario Negri Institute
Pediatric Hematologist/Oncologist
Medical Oncologist
Medical oncologist
District medical officer
Pharmacist
Assistant Professor of Pediatrics
Clinical haematologist
Clinical Haematology and Internal Medicine
Professor in Community Medicine
Paediatric infectious diseases specialist, Fudan University, China
Temporary Advisors
Health economist, Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT).
Professor, Department of Health Research Methods, Evidence, and Impact, McMaster University, Canada
Open session
Agenda
WHO Secretariat and working group presentations
Lorenzo Moja - WHO Essential Medicines List Secretariat
Ana Aceves Capri - WHO Essential Diagnostics List Secretariat
Martina Penazzato - WHO Global Acccelerator for Paediatric Formulations Network (GAP-f) Secretariat
Roberta Ortiz - WHO Global Initiative for Childhood Cancer
Elisabeth de Vries - Chair EML Cancer Medicines
Loice Achieng Ombajo - Chair, WHO Technical Advisory Group on AWaRe
Invited presentations
Participant statements
Albinism Association of Nigeria - Angela Nwokoh
European Society for Medical Oncology - George Pentheroudakis
Global Antibiotic Research and Development Partnership - Fernando Pascual Martinez
Indian Diabetes Organizations - Nupur Lalvani
International Cerebral Palsy Society - John Coughlan
International Federation of Pharmaceutical Manufacturers and Associations - Sergio Cavalheiro Filho
Médecins Sans Frontières - Candice Sehoma
Medicines Patent Pool - Giulia Segafredo
Non Communicable Diseases (NCD) Alliance - Joanna Laurson-Doube
Rare Diseases International - Chiu-Hui (Mary) Wang
Right to Breathe Campaign / Vertex Save Us / Just Treatment - Gayle Pledger and Ajsela Kushova
Union for International Cancer Control - Shalini Jayasekar Zurn
World Federation of Hemophilia - Radoslaw Kaczmarek and Clive Smith
Applications, reviews and comments
Addition of new medicines
Matters arising/outstanding from the 2023 meeting
Late papers
New indications for existing medicines